Editorial Commentary
Suggestions for radiation oncologists to overcome radiotherapy interruption in patients with nasopharyngeal cancer
Abstract
In this issue of Radiotherapy and Oncology, Yao and colleagues report the results of intensity-modulated radiation therapy (IMRT) interruption in patients with nasopharyngeal carcinoma based on big-data intelligence platform analysis including 7,826 patients (1). They showed that increasing radiotherapy (RT) interruption to 7 or more days was significantly negative for survival.